Hammerhead ribozyme-mediated inhibition of hepatitis B virus X gene expression in cultured cells

Journal of Hepatology

Volumn 33, Issue 1, 2000, Pages 142-151

  Weinberg, Marc ^a   Passman, Marc ^a   Kew, Michael ^b   Arbuthnot, Patrick ^a,c  

^a Dept of Molec Med and Haematology ^*  (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Dept Molec Med Haematol 7 Y   (South Africa)

Author keywords

Hepatitis B virus X protein; Hepatocellular carcinoma; Ribozymes; Trans activator

Indexed keywords

RIBOZYME;

ARTICLE; EXPRESSION VECTOR; HEPATITIS B; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS GENE; VIRUS REPLICATION;

EID: 0033917919     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80171-3     Document Type: Article

References (38)

1. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. ii:1981;1129-1133.
2. Robinson WS. Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Ann Rev Med. 45:1994;297-323.
3. Kurstak E. Viral Hepatitis: Current Status and Issues. 1993;Springer-Verlag, Vienna.
4. Mutimer D, Naoumov N, Honkoop P, Marinos G, Ahmed M, de Man R, et al. Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study. J Hepatol. 28:1998;923-929.
5. Ganem D. Assembly of hepadnaviral virions and subviral particles. Mason WS, Seeger C. Hepadnaviruses: Molecular Biology and Pathogenesis. 1991;61-83 Springer-Verlag, Berlin.
6. Chen H, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, et al. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol. 67:1993;1218-1226.
7. Zoulim F, Saputelli J, Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol. 68:1994;2026-2030.
8. Rossner MT. Hepatitis B virus X-gene product: a promiscuous transcriptional activator. J Med Virol. 36:1992;101-117.
9. Klein NP, Schneider RJ. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol. 17:1997;6427-6436.
10. Lee Y-H, Yun Y. HBx protein of hepatitis B virus activates Jak 1-STAT signaling. J Biol Chem. 273:1998;25510-25515.
11. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Stürzbecher H-W, et al. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 55:1995;6012-6016.
12. Lee T, Elledge SJ, Butel JS. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol. 69:1995;1107-1114.
13. Becker SA, Lee T-H, Butel JS, Slagle BL. Hepatitis B virus X protein interferes with cellular DNA repair. J Virol. 72:1998;266-272.
14. Capovilla A, Carmona S, Arbuthnot P. Hepatitis B virus X protein binds damaged DNA and sensitizes liver cells to ultraviolet irradiation. Biochem Biophys Res Commun. 232:1997;255-260.
15. Kim C-M, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature. 351:1991;317-320.
16. Paterlini P, Poussin K, Kew M, Franco D, Bréchot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology. 21:1995;313-321.
17. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature. 317:1985;489-495.
18. Thomson JB, Tuschl T, Eckstein F. The hammerhead ribozyme. Eckstein F, Lilley DMJ. Catalytic RNA. 1997;173-196 Springer-Verlag, Berlin.
19. Usman N, Stuchcomb DT. Design, synthesis and function of therapeutic hammerhead ribozymes. Eckstein F, Lilley DMJ. Catalytic RNA. 1997;243-264 Springer-Verlag, Berlin.
20. Blum HE, Liang TJ, Galun E, Wands J. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology. 14:1991;56-62.
21. Wang C, Stiles CD. Platelet-derived growth factor alpha receptor gene expression: isolation and characterization of the promoter and upstream regulatory elements. Proc Natl Acad Sci USA. 91:1994;7061-7065.
22. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of adenovirus 5 DNA. Virology. 52:1973;456-467.
23. Sanes JR, Rubenstein JLR, Nicolas JF. Use of recombinant retroviruses to study post-implantation cell lineage in mouse embryos. EMBO J. 5:1986;3133-3142.
24. Schaller H, Fischer M. Transcriptional control of hepadnavirus gene expression. Mason WS, Seeger C. Hepadnaviruses: Molecular Biology and Pathogenesis. 1991;21-39 Springer-Verlag, Berlin.
25. Su Q, Schröder CH, Hofman WJ, Otto G, Pichmayr R, Bannasch P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology. 27:1998;1109-1120.
26. Samarsky DA, Ferbeyre G, Bertrand E, Singer RH, Cedergren R, Fournier MJ. A small nucleolar RNA:ribozyme hybrid cleaves a nucleolar RNA target in vivo with near-perfect efficiency. Proc Natl Acad Sci USA. 96:1999;6609-6614.
27. Kim YK, Junn E, Park I, Lee Y, Kang C, Ahn JK. Repression of hepatitis B virus X gene expression by hammerhead ribozymes. Biochem Biophys Res Commun. 257:1999;759-765.
28. Fedor MJ, Uhlenbeck OC. Kinetics of intermolecular cleavage by hammerhead ribozymes. Biochemistry. 31:1992;12042-12054.
29. Hertel KJ, Herschlag D, Uhlenbeck OC. A kinetic and thermodynamic framework for the hammerhead ribozyme reaction. Biochemistry. 33:1994;3374-3385.
30. Welch PJ, Tritz R, Yei S, Barber J, Yu M. Intracellular application of hairpin ribozyme genes against hepatitis B virus. Gene Ther. 4:1997;736-743.
31. Beck J, Nassal M. Efficient hammerhead ribozyme-mediated cleavage of the structured hepatitis B virus encapsidation signal in vitro and in cell extracts, but not in intact cells. Nucl Acids Res. 23:1995;4954-4962.
32. Ruiz J, Wu CH, Ito Y, Wu GY. Design and preparation of a multimeric self-cleaving hammerhead ribozyme. BioTechniques. 22:1997;338-345.
33. Offensperger WB, Blum HE, Gerok W. Therapy of hepadnavirus infection using antisense oligonucleotides. Intervirology. 38:1995;113-119.
34. Offensperger WB, Offensperger S, Blum HE. Antisense therapy of hepatitis B virus infection. Mol Biotechnol. 9:1998;161-170.
35. zu Putlitz J, Wieland S, Blum HE, Wands JR. Antisense RNA complementary to hepatitis B virus specifically inhibits viral replication. Gastroenterology. 115:1998;702-713.
36. Wu GH, Wu CH. Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. J Biol Chem. 267:1992;12436-12439.
37. Nakazono K, Ito Y, Wu CH, Wu GY. Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro. Hepatology. 23:1996;1297-1303.
38. Wu J, Gerber MA. The inhibitory effects of antisense RNA on hepatitis B virus surface antigen synthesis. J Gen Virol. 78:1997;641-647.